BioNTech SE Impairment Loss Recognised In Profit Or Loss
BioNTech SE (BNTX) reported Impairment Loss Recognised In Profit Or Loss of EUR 71.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLoss · last filed 2026-03-10
| Period end | Impairment Loss Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | 71.60M EUR 20-F · filed 2026-03-10 |